Two courses of chemotherapy after orchidectomy for high-risk clinical stage I nonseminomatous testicular tumours

BJU International

Volumn 95, Issue 4, 2005, Pages 477-478

  Swanson, David A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ETOPOSIDE;

CANCER CHEMOTHERAPY; CANCER RELAPSE; COMPUTER ASSISTED TOMOGRAPHY; DRUG SAFETY; EARLY CANCER; EMBRYONAL CARCINOMA; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; NOTE; ORCHIECTOMY; PRIORITY JOURNAL; TESTIS TUMOR;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; HUMANS; LYMPHATIC METASTASIS; MALE; ORCHIECTOMY; RETROPERITONEAL SPACE; RISK FACTORS; TESTICULAR NEOPLASMS;

EID: 14644436459     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05376.x     Document Type: Note

References (5)

1. Pont J, Albrecht W, Postner G, Sellner F, Angel K, Höltl W. Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer. Long-term results of a prospective trial. J Clin Oncol 1996; 14: 441-8
2. Böhlen D, Borner M, Sonntag RW, Fey MF, Studer UE. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. J Urol 1999; 161: 1148-52
3. Wishnow K, Johnson D, Swanson D et al. Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillance. Urology 1989; 34: 339-43
4. Swanson D, von Eschenbach A, Babaian J et al. Is retroperitoneal lymph node dissection (RLND) alone optimal or sufficient therapy for clinical stage I nonseminomatous germ cell testicular tumors (NSGCTT) at high risk for relapse? J Urol 1998; 159 (5, Suppl.): 49
5. Amato RJ, Ro JY, Ayala AG, Swanson DA. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis. Urology 2004; 63: 144-8